Bank of New York Mellon’s Lantern Pharma LTRN Stock Holding History

Bank of New York Mellon’s Portfolio LTRN Stock Details LTRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$88.8K	Hold	21,301	–	–	﹤0.01%	4206
2026 Q1	$29.2K	Sell	21,301 -5,180	-20%	-$14.5K	﹤0.01%	4162
2025 Q4	$80.2K	Hold	26,481	–	–	﹤0.01%	4117
2025 Q3	$115K	Sell	26,481 -1	-0%	-$4	﹤0.01%	4091
2025 Q2	$83.7K	Hold	26,482	–	–	﹤0.01%	4067
2025 Q1	$93.7K	Hold	26,482	–	–	﹤0.01%	4009
2024 Q4	$84.5K	Hold	26,482	–	–	﹤0.01%	4043
2024 Q3	$97.2K	Hold	26,482	–	–	﹤0.01%	4008
2024 Q2	$124K	Hold	26,482	–	–	﹤0.01%	4011
2024 Q1	$233K	Buy	26,482 +1	+0%	+$5	﹤0.01%	3887
2023 Q4	$113K	Hold	26,481	–	–	﹤0.01%	4066
2023 Q3	$90.3K	Buy	26,481 +1	+0%	+$5	﹤0.01%	4094
2023 Q2	$149K	Hold	26,480	–	–	﹤0.01%	4034
2023 Q1	$128K	Hold	26,480	–	–	﹤0.01%	4031
2022 Q4	$160K	Hold	26,480	–	–	﹤0.01%	4031
2022 Q3	$127K	Hold	26,480	–	–	﹤0.01%	4153
2022 Q2	$151K	Sell	26,480 -285	-1%	-$1.7K	﹤0.01%	4144
2022 Q1	$191K	Hold	26,765	–	–	﹤0.01%	4259
2021 Q4	$213K	Hold	26,765	–	–	﹤0.01%	4254
2021 Q3	$299K	Hold	26,765	–	–	﹤0.01%	4038
2021 Q2	$391K	Buy	26,765 +14,990	+127%	+$232K	﹤0.01%	3886
2021 Q1	$213K	Buy	+11,775	New	+$206K	﹤0.01%	4032

Other funds holding LTRN

EAM

Empery Asset Management New York $86.5M AUM

WIM

Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return

HKAM

Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Bank of New York Mellon's LTRN Position: Q2 2026 in Review

Bank of New York Mellon held its Lantern Pharma (LTRN) position steady in Q2 2026 at 21,301 shares worth $88.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4206.

Bank of New York Mellon first reported a position in LTRN in Q1 2021 and has held it in 22 quarters since. The position peaked at $391K in Q2 2021. 17 funds tracked by Wall St. Rank hold LTRN as of Q2 2026.

Bank of New York Mellon held 21,301 shares of Lantern Pharma worth $88.8K as of Q2 2026.
Bank of New York Mellon left its Lantern Pharma share count unchanged in Q2 2026.
Lantern Pharma made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #4206 holding.
Bank of New York Mellon first reported a position in Lantern Pharma in Q1 2021 and has held it in 22 quarters since.
Bank of New York Mellon's Lantern Pharma position peaked at $391K in Q2 2021.
17 funds tracked by Wall St. Rank held Lantern Pharma as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.